| Original language | English (US) |
|---|---|
| Pages (from-to) | 37-38 |
| Number of pages | 2 |
| Journal | Clinical Breast Cancer |
| Volume | 2 |
| Issue number | 1 |
| State | Published - 2001 |
| Externally published | Yes |
Fingerprint
Chemoprevention
Tamoxifen
ASJC Scopus subject areas
- Cancer Research
Cite this
Commentary on "Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials". / Sparano, Joseph A.
In: Clinical Breast Cancer, Vol. 2, No. 1, 2001, p. 37-38.Research output: Contribution to journal › Article
Sparano, JA 2001, 'Commentary on "Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials"', Clinical Breast Cancer, vol. 2, no. 1, pp. 37-38.
@article{1279d4ea064746629dc0bcd48ad1de89,
title = "Commentary on {"}Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials{"}",
author = "Sparano, {Joseph A.}",
year = "2001",
language = "English (US)",
volume = "2",
pages = "37--38",
journal = "Clinical Breast Cancer",
issn = "1526-8209",
publisher = "Elsevier",
number = "1",
}
TY - JOUR
T1 - Commentary on "Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials"
AU - Sparano, Joseph A.
PY - 2001
Y1 - 2001
UR - http://www.scopus.com/inward/record.url?scp=0035004575&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035004575&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0035004575
VL - 2
SP - 37
EP - 38
JO - Clinical Breast Cancer
JF - Clinical Breast Cancer
SN - 1526-8209
IS - 1
ER -